These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34738562)

  • 21. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus.
    Cheng HP; Wong JSL; Selveindran NM; Hong JYH
    Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Lockdown and Physical Activity on Glycemic Control in Italian Children and Young Patients With Type 1 Diabetes.
    Minuto N; Bassi M; Montobbio C; Vinci F; Mercuri C; Perri FN; Cabri M; Calevo MG; d'Annunzio G; Maghnie M
    Front Endocrinol (Lausanne); 2021; 12():690222. PubMed ID: 34326814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies.
    Han Y; Chen Y; Sun C; Zhou Z
    Front Endocrinol (Lausanne); 2022; 13():1069559. PubMed ID: 36531473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

  • 25. The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases.
    Evin F; Er E; Ata A; Jalilova A; Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):468-472. PubMed ID: 33084289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
    Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
    J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes During 1 Year of the COVID-19 Pandemic.
    Kaushal T; Tinsley L; Volkening LK; Ambler-Osborn L; Laffel L
    Diabetes Technol Ther; 2022 Feb; 24(2):136-139. PubMed ID: 34524008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
    Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes.
    Shah N; Karguppikar M; Bhor S; Ladkat D; Khadilkar V; Khadilkar A
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):217-223. PubMed ID: 33185578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic control during the first two years of the COVID-19 pandemic in pediatric patients with type 1 diabetes: results from the German DPV initiative.
    Hammersen J; Tittel SR; Khodaverdi S; Reschke F; Flury M; Menzel U; Mönkemöller K; Meissner T; Karges B; Holl RW
    Acta Diabetol; 2023 Jun; 60(6):757-766. PubMed ID: 36871116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight gain in type 1 diabetes during the SARS-CoV-2 pandemic. Does lockdown affect the metabolic control of pediatric patients?
    Zubkiewicz-Kucharska A; Wikiera B; Noczyńska A
    Front Endocrinol (Lausanne); 2022; 13():991269. PubMed ID: 36313778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic.
    Bassi M; Strati MF; Parodi S; Lightwood S; Rebora C; Rizza F; d'Annunzio G; Minuto N; Maghnie M
    Front Public Health; 2022; 10():857561. PubMed ID: 35392480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the COVID-19 quarantine on metabolic control in children and adolescents with type 1 diabetes.
    Turan H; Güneş Kaya D; Tarçın G; Evliyaoğlu SO
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):201-208. PubMed ID: 35396118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring.
    Longo M; Scappaticcio L; Petrizzo M; Castaldo F; Sarnataro A; Forestiere D; Caiazzo F; Bellastella G; Maiorino MI; Capuano A; Esposito K
    J Endocrinol Invest; 2022 Feb; 45(2):445-452. PubMed ID: 34482534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format.
    Schiller T; Zornitzki T; Ostrovsky V; Sapojnik D; Cohen L; Kunyavski T; Knobler H; Kirzhner A
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic.
    Ali N; El Hamdaoui S; Nefs G; Tack CJ; De Galan BE
    BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35606020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical Activity in Adolescents with and without Type 1 Diabetes during the New Zealand COVID-19 Pandemic Lockdown of 2020.
    Telford DM; Signal DM; Hofman PL; Gusso S
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33922464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study.
    D'Onofrio L; Pieralice S; Maddaloni E; Mignogna C; Sterpetti S; Coraggio L; Luordi C; Guarisco G; Leto G; Leonetti F; Manfrini S; Buzzetti R
    Diabetes Obes Metab; 2021 Jul; 23(7):1624-1630. PubMed ID: 33764666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.